A phenomenon that transiently increases the permeability of the cells is known as electroporation. It is the basis for number of the applications in biomedical domains. It is essential to consider requirement of high precision and the overall size of electroporator. The recent decades have seen the development of solid-state power electronic modules. The modules enable generation of high voltage millisecond and nano-second pulses with options to reduce the overall size of the equipment. The selective modules are verified with experimental models and available for commercial usage. While the other modules are still undergoing optimization processes. The generator generates pulses for varying performances. Hence, this paper presents knowledge for different nanosecond and millisecond pulse generating circuits for electroporation purposes. The performance parameters like the width of the pulse, its amplitude are compared for different circuit topologies. The performance analysis of different topologies and their impact on the performance of the electroporation at the cell biology level are considered in this paper.

Electroporation is a next generation bioelectronics device. The emerging application of electroporation requires high voltage pulses having a pulse-width in the nanosecond range. The essential use of a capacitor results in an increase in the size of the electroporator circuit. This paper discusses the modification of a conventional Marx generator circuit to achieve the high voltage electroporation pulses with a minimal chip size of the circuit. The reduced capacitors are attributed to a reduction in the number of stages used to achieve the required voltage boost. The paper proposes the improved isolation between two capacitors with the usage of optocouplers. Parametric analysis is presented to define the tuneable range of the electroporator circuit. The output voltage of 49.4 V is achieved using the proposed 5-stage MOSFET circuit with an input voltage of 12 V.

Electroporation has an application in the selective delivery of drugs explicitly into cells. However, the challenge is to achieve efficiency in delivering the drugs. The key parameter responsible for successful electroporation-mediated drug delivery is induced transmembrane voltage (ITMV). The Food & Drug Administration (FDA) has recently approved the clinical trials of DNA plasmid delivery of the COVID-19 vaccine through electroporation. The requirement is to develop a COVID-19 vaccine within a limited time. Hence, the extensive amount of laboratory experiments are not feasible. It has increased dependency on simulation-based analysis. The simulations of electroporation depend on ITMV expression for the specified cell and the environment. In this paper, we have derived the closed-form expression of ITMV (∆Vm). The closed-form expression is used in COMSOL Multiphysics simulation to obtain extracellular concentration variation as a function of time. The simulation results match the empirical results from the literature and hence validate the closed-form expression. The closed-form expression will reduce the development time of electroporation-assisted COVID-19 vaccine delivery.

No abstract